• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » More defections scuttle Republican plan to repeal Obamacare without replacement

More defections scuttle Republican plan to repeal Obamacare without replacement

July 19, 2017 By Brad Perriello

Capitol HillRepublican efforts repeal Obamacare despite the failure of their replacement healthcare reform plan likewise collapsed late yesterday, after a trio of moderate GOPers said they wouldn’t support the measure.

Following the Trumpcare flameout yesterday, majority leader Sen. Mitch McConnell (R-Ky.) announced a vote on a straight repeal of Obamacare to take effect in two years, planning a vote “early next week.”

But Sens. Shelley Moore Capito (R-W.Va.), Susan Collins (R-Maine) and Lisa Murkowski (R-Alaska) quickly announced they would not back repeal, all but spelling doom for the repeal-without-replacement move given McConnell’s razor-thin margin – with a 52-member majority he must win over at least 50 senators to win – and Democrats’ implacable opposition to cutting away or killing Obamacare.

“To repeal there has to be a replacement. There’s enough chaos already, and this would just contribute to it,” Murkowski told reporters late yesterday.

“I do not think that it’s going to be constructive to repeal a law that at this point is so interwoven within our healthcare system and then hope that over the next two years we will come up with some kind of replacement,” Collins added.

Legislators are not the only ones opposed to the Trumpcare proposals. The latest version is manifestly unpopular even in counties that went for the president during the election. In contrast, Obamacare’s popularity is growing. A Washington Post-ABC News poll this week showed that Americans preferred it over the Republican alternative by a 2-1 margin.

The disarray in the Republican-controlled Senate rattled financial markets, casting doubt on investors’ hopes for industry-friendly tax reform and infrastructure bills.

The U.S. dollar stumbled to a 10-month low against a basket of currencies and U.S. Treasury yields fell after the fresh setback to the healthcare bill raised investors’ doubts about Trump’s ability to enact tax cuts and infrastructure spending. Reaction in the stock market was muted, and analysts said the expectation for business-friendly legislation out of Washington is all but priced out of the stock market.

“The healthcare hurdle pushes everything in Trump’s agenda to 2018,” said Art Hogan, chief market strategist at Wunderlich Securities in New York.

Material from Reuters was used in this report.

Filed Under: Healthcare Reform, Wall Street Beat Tagged With: Capitol Hill

More recent news

  • Johnson & Johnson MedTech launches new Volt plating systems for radius, humerus
  • PharmaSens, SiBionics collab on all-in-one insulin patch pump
  • Beta Bionics to pair iLet automated insulin delivery system with Abbott’s dual glucose-ketone sensor
  • Anaconda Biomed wins CE mark for funnel catheter
  • FDA approves Neuspera neuromod for urinary incontinence

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy